
Dr. Nasha recently joined JJ Flizanes on her podcast to talk about “The Therapeutic Use of Psychedelics for Emotional Breakthroughs.”
Dr. Nasha Winters, ND, FABNO, is a sought-after luminary and global healthcare authority in integrative cancer research. She consults with physicians around the world bridging ancient therapies with advancements in modern medicine in the digital era. Dr. Nasha’s personal journey with cancer over the past 32 years has transformed into a mission to support others facing similar challenges. Through her influential books, “The Metabolic Approach to Cancer” and “Mistletoe and the Emerging Future of Integrative Oncology,” she has empowered individuals seeking prevention and ongoing treatment options for cancer.
During this podcast, Dr. Nasha and JJ take a deep dive into Psylocibin and it’s use in Emotional Breakthroughs.
About JJ Flizanes
JJ Flizanes is an Empowerment Strategist and the host of several podcasts including People’s Choice Awards nominee Spirit, Purpose & Energy. JJ Flizanes works with conscious, spiritual truth seekers who want to remove emotional blocks to success. She helps people identify sabotaging patterns and transmute struggle into joy. Through a series of clarifying exercises, she is able to curate a personalized roadmap to emotional healing. JJ is passionate about empowering people with the knowledge and awareness of how they can live the life of their dreams. http://jjflizanes.com

Related Articles
Test First. Don’t Guess: How Andrea Schaffer Used Data to Take Charge of Her Cancer Journey
Lynn Hughes
Sep 1, 2026
Movement Is Medicine: The Way You Move Matters More Than You Think
Lynn Hughes
Aug 11, 2026
What Does Your Immune System Have to Do with Cancer?
Lynn Hughes
Aug 3, 2026
Become the CEO of Your Health: Three Lessons from Laura Lummer's Cancer Journey
Lynn Hughes
Jul 28, 2026
Your Prognosis Is Not Your Destiny: Lessons in Hope, Healing, and Self-Advocacy with Dale Weber
Lynn Hughes
Jul 14, 2026
Reset Your Habits with a 14-Day Clean Eating Challenge
Lynn Hughes
Jul 13, 2026
